1. Home
  2. SMTI vs MTLS Comparison

SMTI vs MTLS Comparison

Compare SMTI & MTLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sanara MedTech Inc.

SMTI

Sanara MedTech Inc.

N/A

Current Price

$34.96

Market Cap

313.5M

Sector

Health Care

ML Signal

N/A

Logo Materialise NV

MTLS

Materialise NV

HOLD

Current Price

$7.67

Market Cap

431.6M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
SMTI
MTLS
Founded
1982
1990
Country
United States
Belgium
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
313.5M
431.6M
IPO Year
2008
2014

Fundamental Metrics

Financial Performance
Metric
SMTI
MTLS
Price
$34.96
$7.67
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$34.00
N/A
AVG Volume (30 Days)
325.8K
119.8K
Earning Date
05-12-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$15,586,976.00
N/A
Revenue This Year
$17.31
$6.38
Revenue Next Year
$12.48
$6.45
P/E Ratio
N/A
$61.39
Revenue Growth
32.47
N/A
52 Week Low
$16.05
$4.78
52 Week High
$35.70
$7.67

Technical Indicators

Market Signals
Indicator
SMTI
MTLS
Relative Strength Index (RSI) 78.05 61.34
Support Level $33.99 $6.37
Resistance Level N/A $7.50
Average True Range (ATR) 0.26 0.27
MACD -0.26 0.06
Stochastic Oscillator 93.10 80.33

Price Performance

Historical Comparison
SMTI
MTLS

About SMTI Sanara MedTech Inc.

Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.

About MTLS Materialise NV

Materialise NV is a provider of 3D-printed medical devices and software and a pioneer in additive manufacturing software and services. The company operates through three principal segments: Materialise Software, Materialise Medical, and Materialise Manufacturing, with the Materialise Medical segment generating maximum revenue. The Materialise Medical segment develops and delivers medical software solutions, medical devices, and related products and services; the Materialise Software segment develops and delivers additive manufacturing software solutions and related services; and the Materialise Manufacturing segment delivers 3D-printed products and related services. The company generates maximum revenue from the United States of America.

Share on Social Networks: